Related Experiment Videos
Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study
1Medical College of Georgia, School of Medicine, Augusta, USA.
Clinical Therapeutics
|July 1, 1996
Summary
Switching antipsychotic medications requires careful management to minimize withdrawal symptoms. Clinicians can reduce adverse effects during antipsychotic transitions by considering patient history and employing strategies like gradual dose reduction or overlapping therapies.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Antipsychotic medication is crucial for managing psychoses.
- Treatment changes are often necessary due to side effects or lack of efficacy.
- Discontinuation of antipsychotics can lead to withdrawal symptoms.
Framework:
- Antipsychotic withdrawal syndromes can include psychosis recurrence, dyskinesia, and cholinergic rebound.
- Common withdrawal symptoms include insomnia, nausea, vomiting, anxiety, and agitation.
- Individualized patient assessment is key to managing transitions.
Implementation:
- Switching to risperidone necessitates careful consideration of patient's clinical history and status.
- Strategies for minimizing withdrawal include abrupt discontinuation, gradual dose reduction, or overlapping therapies.
- Overlapping the existing antipsychotic with risperidone is often the preferred method.
Implications:
- Effective management of antipsychotic transitions can improve patient outcomes.
- Minimizing withdrawal symptoms enhances treatment adherence and tolerability.
- This approach supports safer and more effective management of psychotic disorders.